Cite

HARVARD Citation

    Darvishian, M. et al. (2020). Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies. Journal of viral hepatitis. 27 (3), pp. 243-260. [Online]. 
  
Back to record